8-K: Intensity Therapeutics Updates Preliminary Financials
Financial Update
Intensity Therapeutics, Inc. furnished an updated financial highlights slide for the period ending December 31, 2025, noting the figures are unaudited and preliminary.
Summary
- Intensity Therapeutics, Inc. (the Company) updated its Financial Highlights Slide through December 31, 2025.
- The updated slide is available on the Investor Relations section of the Company's website.
- All figures presented in the slide are unaudited and preliminary.
- These preliminary figures are subject to the completion of financial closing procedures, including management's reviews.
- The final amounts that will be reflected in the Company's financial statements as of and for the year ended December 31, 2025, may differ materially from the preliminary figures.
- The information in this Item 2.02, including Exhibit 99.1, is furnished and not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liabilities of that Section.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral update, as it merely announces the availability of preliminary financial highlights without providing the actual figures or any substantive new information.
Risks
- The preliminary and unaudited financial figures presented in the Financial Highlights Slide may differ materially from the amounts that will be reflected in the Company's final audited financial statements as of and for the year ended December 31, 2025.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that without the specific financial highlights, it is difficult to assess the immediate industry implications of this update. The filing primarily serves as a procedural announcement regarding the availability of preliminary data.
Stakeholder Impact
- Shareholders and potential investors are provided with preliminary financial highlights, which are explicitly stated to be unaudited and subject to material change upon completion of audited financial statements.
Key Dates
| Date | Description |
|---|---|
| 2025-12-31 | Period end date for the financial highlights presented in the updated slide. |
| 2026-03-04 | Date of the Financial Highlights Slide (Exhibit 99.1). |
| 2026-03-05 | Date of earliest event reported and date the Company updated the Financial Highlights Slide. |
Keywords
Intensity Therapeutics, INTS, 8-K filing, financial highlights, investor presentation, preliminary results, unaudited financials, corporate update
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.